JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Matsons
MATX
$6.11B
| $23.6M | ﹤0.01% |
303,533
+8,523
| +3% | +$584K |
|
1552
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$675M
| $23.6M | ﹤0.01% |
400,683
-19,004
| -5% | -$1.08M |
|
1553
Customers Bancorp
CUBI
$2.66B
| $23.6M | ﹤0.01% |
778,514
+738,939
| +1,867% | +$16.6M |
|
1554
Popular Inc
BPOP
$11B
| $23.6M | ﹤0.01% |
389,160
+37,768
| +11% | +$2.23M |
|
1555
CALL
Regeneron Pharmaceuticals
REGN
$72.9B
| $23.5M | ﹤0.01% |
32,700
-137,200
| -81% | -$106M |
|
1556
F5
FFIV
$22B
| $23.5M | ﹤0.01% |
160,474
+3,349
| +2% | +$476K |
|
|
SYNH
1557
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $23.4M | ﹤0.01% |
554,483
-1,737,501
| -76% | -$70.3M |
|
1558
Skywest
SKYW
$4.35B
| $23.3M | ﹤0.01% |
572,940
+56,164
| +11% | +$1.67M |
|
1559
BWX Technologies
BWXT
$14.4B
| $23.3M | ﹤0.01% |
325,694
+78,528
| +32% | +$5.13M |
|
1560
CALL
Lam Research
LRCX
$316B
| $23.1M | ﹤0.01% |
360,000
+356,000
| +8,900% | +$20.1M |
|
1561
Indivior Pharmaceuticals
INDV
$4.74B
| $23.1M | ﹤0.01% |
+970,623
| New | +$22.2M |
|
1562
Vistra
VST
$48.2B
| $23.1M | ﹤0.01% |
878,189
+18,922
| +2% | +$462K |
|
1563
California Resources
CRC
$4.49B
| $23M | ﹤0.01% |
508,158
+401,553
| +377% | +$16.3M |
|
1564
MGE Energy Inc
MGEE
$3.03B
| $23M | ﹤0.01% |
290,851
+114,273
| +65% | +$8.77M |
|
1565
Constellium
CSTM
$3.76B
| $23M | ﹤0.01% |
1,335,977
+394,193
| +42% | +$6.05M |
|
|
DFUS
1566
Dimensional US Equity ETF
DFUS
$20.3B
| $23M | ﹤0.01% |
476,881
+150,887
| +46% | +$6.86M |
|
1567
Artisan Partners
APAM
$2.86B
| $23M | ﹤0.01% |
583,823
+451,312
| +341% | +$15.6M |
|
1568
Victory Capital Holdings
VCTR
$6.09B
| $22.9M | ﹤0.01% |
727,054
+566,364
| +352% | +$17.5M |
|
1569
Jones Lang LaSalle
JLL
$15.8B
| $22.9M | ﹤0.01% |
147,176
-18,393
| -11% | -$2.61M |
|
1570
RELX
RELX
$66.8B
| $22.9M | ﹤0.01% |
685,337
+87,640
| +15% | +$2.82M |
|
1571
PUT
AB InBev
BUD
$164B
| $22.9M | ﹤0.01% |
403,300
+279,500
| +226% | +$16.9M |
|
1572
CALL
Mastercard
MA
$498B
| $22.9M | ﹤0.01% |
58,100
+2,600
| +5% | +$976K |
|
1573
Graphic Packaging
GPK
$3.35B
| $22.8M | ﹤0.01% |
948,704
+697,751
| +278% | +$17.5M |
|
1574
iShares Russell Top 200 ETF
IWL
$2.13B
| $22.8M | ﹤0.01% |
213,465
+13,211
| +7% | +$1.33M |
|
1575
Jackson Financial
JXN
$8.4B
| $22.7M | ﹤0.01% |
742,492
+273,494
| +58% | +$8.81M |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.